围绝经期和绝经后中国女性骨量相关代谢物的鉴定与功能表征
孟德尔随机化分析显示十二烷酸(DA)因果性降低全髋骨密度,体内外实验提示DA可促进骨丢失并增加破骨细胞分化。
要点
- 脂肪酸代谢模块与围绝经期和绝经后女性骨密度变异显著相关
- 十二烷酸因果性降低全髋骨密度,动物实验支持其促进骨丢失
- 十二烷酸在较高浓度下促进破骨细胞分化,提示脂肪酸在骨质疏松中的作用
核心结论
- 本研究揭示与绝经后骨质疏松风险相关的代谢组学特征,强调脂肪酸(以十二烷酸为例)在调控骨密度中的潜在重要性。
研究设计与样本
- 横断面研究,纳入517名41至64岁围绝经期(16%)和绝经早期(84%)中国女性,进行血清代谢组学分析及全基因组测序。
主要发现
- 孟德尔随机化分析发现十二烷酸因果性降低全髋骨密度。
- 体内实验提示膳食补充十二烷酸可促进正常/去卵巢小鼠骨丢失,并增加成骨细胞和破骨细胞数量。
- 体外实验显示十二烷酸差异促进成骨细胞和破骨细胞分化,较高浓度(如10、100 μM)尤其促进破骨细胞分化。
关键数值与推荐
- 十二烷酸在10、100 μM浓度下体外促进破骨细胞分化。
临床怎么用
- 血清脂肪酸代谢物(如十二烷酸)可能作为围绝经期和绝经后女性骨密度变化的潜在生物标志物。
- 针对脂肪酸代谢的干预或可为绝经后骨质疏松风险提供新的管理思路。
局限性
- 横断面设计无法确定代谢物与骨密度变化的时间顺序。
- 研究人群限于41至64岁中国女性,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Although metabolic profiles appear to play an important role in menopausal bone loss, the functional mechanisms by which metabolites influence bone mineral density (BMD) during menopause are largely unknown. OBJECTIVE: We aimed to systematically identify metabolites associated with BMD variation and their potential functional mechanisms in peri- and postmenopausal women. DESIGN AND METHODS: We performed serum metabolomic profiling and whole-genome sequencing for 517 perimenopausal (16%) and early postmenopausal (84%) women aged 41 to 64 years in this cross-sectional study. Partial least squares regression and general linear regression analysis were applied to identify BMD-associated metabolites, and weighted gene co-expression network analysis was performed to construct co-functional metabolite modules. Furthermore, we performed Mendelian randomization analysis to identify causal relationships between BMD-associated metabolites and BMD variation. Finally, we explored the effects of a novel prominent BMD-associated metabolite on bone metabolism through both in vivo/in vitro experiments. RESULTS: Twenty metabolites and a co-functional metabolite module (consisting of fatty acids) were significantly associated with BMD variation. We found dodecanoic acid (DA), within the identified module causally decreased total hip BMD. Subsequently, the in vivo experiments might support that dietary supplementation with DA could promote bone loss, as well as increase the osteoblast and osteoclast numbers in normal/ovariectomized mice. Dodecanoic acid treatment differentially promoted osteoblast and osteoclast differentiation, especially for osteoclast differentiation at higher concentrations in vitro (eg,10, 100 μM). CONCLUSIONS: This study sheds light on metabolomic profiles associated with postmenopausal osteoporosis risk, highlighting the potential importance of fatty acids, as exemplified by DA, in regulating BMD.
引用
- Gong R, Xiao HM, Zhang YH, et al. Identification and Functional Characterization of Metabolites for Bone Mass in Peri- and Postmenopausal Chinese Women. J Clin Endocrinol Metab. 2021. PMID: 33693744. doi:10.1210/clinem/dgab146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。